Romy Megahed, MD

UAMS Radiation Oncology
Little Rock, AR

Disclosures:

Presentations

Sep 30

1103 - SETD2 Loss Predicts Response to Chemoradiotherapy in Rectal Cancer: Clinical Outcomes and Preclinical Validation in Orthotopic Models
05:25pm - 05:30pm PT
Sep 28

2177 - Interstitial Brachytherapy for Soft Tissue Sarcomas: Outcomes and Patterns of Failure Patterns from a Single Institution Experience
Hall F
02:30pm - 04:00pm PT
Sep 28

2178 - Intensity Modulated Proton Therapy with Robust Optimization to Mitigate Inter-Fractional Variations
Hall F
02:30pm - 04:00pm PT